Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-25
DOI
10.1038/srep22089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer
- (2016) Young Suk Kwon et al. Clinical Genitourinary Cancer
- Neutrophil count is associated with survival in localized prostate cancer
- (2015) Houda Bahig et al. BMC CANCER
- Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer
- (2015) C-H Koh et al. BRITISH JOURNAL OF CANCER
- High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma
- (2015) J. Zaragoza et al. BRITISH JOURNAL OF DERMATOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Corticosteroids in the Management of Prostate Cancer: A Critical Review
- (2015) Chukwuma Ndibe et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy
- (2015) Akihisa Yao et al. INTERNATIONAL JOURNAL OF UROLOGY
- Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer
- (2015) Nathan A. Cannon et al. Journal of Thoracic Oncology
- MP66-05 PRETREATMENT SYSTEMIC INFLAMATORY RESPONSE PARAMETERS DO NOT PREDICT THE OUTCOME IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY
- (2015) Cédric Poyet et al. JOURNAL OF UROLOGY
- MP6-05 THE ASSOCIATION OF PREOPERATIVE NEUTROPHIL TO LYMPHOCYTE RATIO WITH ONCOLOGIC OUTCOMES FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE CANCER
- (2015) Vidit Sharma et al. JOURNAL OF UROLOGY
- The Association of Platelet Count with Clinicopathological Significance and Prognosis in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
- (2015) Liangyou Gu et al. PLoS One
- Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma
- (2015) Hao Duan WORLD JOURNAL OF GASTROENTEROLOGY
- Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients
- (2015) Tanja Langsenlehner et al. WORLD JOURNAL OF UROLOGY
- High preoperative neutrophil–lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy
- (2015) Hakmin Lee et al. WORLD JOURNAL OF UROLOGY
- Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis
- (2015) K. Hu et al. BMJ Open
- Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis
- (2015) Xiao-Bin Gu et al. Scientific Reports
- Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
- (2014) D. Lorente et al. ANNALS OF ONCOLOGY
- Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials†
- (2014) R. J. van Soest et al. ANNALS OF ONCOLOGY
- Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone
- (2014) Min Wei et al. BMC CANCER
- Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio
- (2014) Arnoud J. Templeton et al. CANCER
- Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer
- (2014) In Rae Cho et al. Gastric Cancer
- Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel
- (2014) Ahmet Taner Sümbül et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Prostate Cancer in the Elderly Patient
- (2014) Chunkit Fung et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- Prognostic Role of NLR in Urinary Cancers: A Meta-Analysis
- (2014) Yong Wei et al. PLoS One
- Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel
- (2013) Philipp Nuhn et al. BJU INTERNATIONAL
- Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
- (2013) J Szkandera et al. BRITISH JOURNAL OF CANCER
- Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy
- (2013) Anthony Linton et al. Clinical Genitourinary Cancer
- Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis
- (2013) Mu-Xing Li et al. INTERNATIONAL JOURNAL OF CANCER
- A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
- (2012) M J Proctor et al. BRITISH JOURNAL OF CANCER
- Tumor-Associated Neutrophils: New Targets for Cancer Therapy
- (2011) A. D. Gregory et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study
- (2011) K Shafique et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
- Prostate cancer
- (2008) Jan-Erik Damber et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started